https://charts.traderzeitung.de/phases/US7995661045 string(1459) "{"isin":"US7995661045","name":"Sana Biotechnology Inc","stock_id_xnas":16776261,"stock_id_xnys":null,"generated_at":"2026-09-24 01:32:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":3.13,"close_at":"2026-09-21 15:29:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.105,"close_at":"2026-09-21 21:59:00","complete":true,"perf_pct":-0.7987},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.335,"close_at":"2026-09-22 21:59:00","complete":true,"perf_pct":7.4074},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":3.28,"close_at":"2026-09-22 23:10:00","complete":true,"perf_pct":-1.6492}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":3.08,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-6.0976},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":3.12,"close_at":"2026-09-24 01:22:00","complete":false,"perf_pct":1.2987}]}]}"

Sana Biotechnology Aktie News & Nachrichten

[WKN: A2QNUE | Symbol: SANA]

Realtimekurs

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

08.01.2025 um 16 Uhr

Sana Biotechnology

Stocks in Action USA: D-Wave Quantum, LifeVantage (LFVN), Sana Biotechnology (SANA)

NVIDIA-CEO Jensen Huang bremst die Erwartungen und schickt damit Quantencomputing-Aktien in eine massive...

Sana Biotechnology Nachrichtenticker öffnen

MT Newswires 14.08.2026 13:47 Uhr

BofA Securities passt Kursziel für Sana Biotechnology von $7 auf $6 an

MT Newswires 10.08.2026 22:16 Uhr

Sana Biotechnology verringert bereinigten Verlust im Q2

04:15 PM EDT, 08/10/2026 (MT Newswires) -- Sana Biotechnology (SANA) meldete am späten Montag einen bereinigten Verlust im Q2 von 0,13 USD je verwässe

MT Newswires 10.08.2026 22:07 Uhr

-- Earnings Flash (SANA) Sana Biotechnology, Inc. verzeichnet im Q2 einen bereinigten Verlust von 0,13 $ je Aktie, verglichen mit der FactSet-Schätzung von -0,12 $